We Are Part of The Sartorius Stedim Biotech Group, a Global Provider of Laboratory and Pharmaceutical Equipment.

Based near Cambridge UK, we specialize in the design and manufacture of automated cell culture and fermentation systems for the bio-pharma, regenerative medicine and industrial biotechnology sectors, focusing on:

  • Bioprocess Development
  • GMP Manufacture of Biologics
  • Cell Therapy and Stem Cell Research
  • Discovery Research




Sartorius introduces BioPAT® Spectro to enable Raman spectroscopy capability and QbD with its ambr® and BIOSTAT STR® platforms More >>

New ambr® 250 Modular Bioreactor Vessel Launched for Cell and Gene Therapy Applications More >>

Sartorius Stedim Biotech launches new ambr(R) 15 cell culture microbioreactor system More >>

Sartorius Stedim Biotech Introduces Mini Microcarrier Bioreactor for Culturing Adherent Cells More >>

Sartorius Stedim Biotech launches new ambr® 250 high throughput bioreactor system for perfusion culture More >>

Engineer Wins Second Cambridge Regional College Award More >>

Ingenza invests in ambr 250 modular technology for fast fermentation development More >>

Local Firms Invited to Join Exciting STEM Initiative - Helping Children Understand the Appliance of Science More >>

Sartorius Stedim Biotech launches ambr® 15 bioreactor system with Nova BioProfile® FLEX2 integration More >>

Sartorius Stedim Biotech Partners with Nova Biomedical - Firms combine ambr® technology with the BioProfile® FLEX2 More >>

Award-Winning Engineering Apprenticeship Scheme at Royston site now open for applications More >>

New Webinar on Implementing the ambr® 250 Modular Benchtop Bioreactor - With A Case Study From Cobra Biologics More >>

New Webinar on Developing Process Workflows for Rapid Scale-Up - With a Case Study from WuXi Biologics More >>

Sartorius Stedim Biotech launches innovative ambr® 250 modular bioreactor system More >>

WuXi Biologics and Sartorius Stedim Biotech Open Joint R&D Biologics Laboratory in Shanghai More >>

New Poster on High Density Fed-Batch Microbial Screening Using Micro Bioreactors More >>

Sartorius Royston actively recruiting for a variety of roles within this growing business More >>

Science and Technology Workshops Launched for Primary & Middle Schools More >>

Sartorius Royston wins STEM Apprenticeship Employer of the Year and Overall Employer of the Year Awards More >>

Ginkgo Bioworks chooses ambr® 250 Systems to enable High Throughput Process Development of Engineered Microbes More >>

New paper from WuXi AppTec on Shortening Timelines for Bioprocessing of Protein-based Therapeutics More >>

New Webinar - ambr15 microbioreactor as a sedimentation-perfusion model More >>

New SelecT Mk5 Automated Cell Culture System Launched on Booth 1223 at SLAS More >>

New ambr 15 fermentation system for enhanced microbial strain screening More >>

RAFT 3D cell culture system to be exclusively distributed by Lonza Bioscience More >>

ReNeuron to use Cellmate Automated Cell Culture for Stem Cell-based Stroke Therapy More >>

New webinar: Using ambr 250 for effective scale-up to cGMP manufacture of biotherapeutics More >>

ambr 15 and ambr 250 bioreactor systems enhanced with Design of Experiments (DoE) software More >>


BioPAT Spectro for Ambr Systems
Focus on: BioPAT® Spectro for Ambr® Systems

BioPAT® Spectro embraces Quality by Design (QbD) principles to unlock the full potential of Raman spectroscopy. Automated data acquisition and consolidation in high-throughput, small scale Ambr® system leads to highly robust models that can be applied in high-throughput process development and are easily transferred to manufacturing in single-use Flexsafe STR® bags.

BioPAT® Spectro is compatible with the two leading providers of Raman spectrometers (Kaiser Optical Systems; Tornado Spectral Systems), with the potential to add further suppliers in the future.



View our Latest Job Opportunities